MDT Q2 2025 Earnings — Medtronic plc Revenue & Financial Results | Market Cap Arena

MDTMedtronic plc

$116B

Q2 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$8.4B+5.2% YoY

Gross Profit

$5.5B64.9% margin

Operating Income

$1.6B19.0% margin

Net Income

$1.3B15.1% margin

EPS (Diluted)

$0.99

QoQ Revenue Growth

+6.2%

Cash Flow

Operating Cash Flow

$958M

Free Cash Flow

$554M

Stock-Based Comp.

$159M

Balance Sheet

Total Assets

$90.0B

Total Liabilities

$41.3B

Stockholders' Equity

$48.5B

Cash & Equivalents

$1.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8.4B	$8.0B	+5.2%
Gross Profit	$5.5B	$5.2B	+4.5%
Operating Income	$1.6B	$1.3B	+19.0%
Net Income	$1.3B	$909M	+39.7%

Revenue Segments

Cardiac and Vascular Group

$3.1B37%

Neuroscience Group

$2.5B29%

Medical Surgical

$2.1B25%

Diabetes Group

$686M8%

Geographic Segments

UNITED STATES

$4.3B51%

Total Other Countries, Excluding United States and Ireland

$4.1B48%

IRELAND

$29M0%